GlassScriptPhysician profile
Viki Lambertus
NPI 1265746002
$522.61
in general payments reported to CMS, 2019-2025
20 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $56.08 · 2022: $33.26 · 2023: $75.97 · 2024: $240 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $66.67 | 2023-2024 | |
| Gilead Sciences, INC. | $52.30 | 2024 | |
| Indivior INC. | $50.33 | 2022-2025 | Sublocade |
| Abbott Laboratories | $46.43 | 2024 | Freestyle Libre 3 |
| Novo Nordisk INC | $39.52 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $30.37 | 2021-2025 | |
| Xeris Pharmaceuticals, INC. | $28.64 | 2023-2024 | Gvoke Hypopen |
| Glaxosmithkline, LLC. | $28.00 | 2022-2024 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.15 | 2021 | |
| Exact Sciences Corporation | $16.97 | 2025 | Cologuard Collection Kit |
| Braeburn INC. | $16.67 | 2024 | Brixadi |
| Hologic Sales and Service, LLC | $16.65 | 2025 | Thinprep 2000 Processor, Aptima |
| Daiichi Sankyo INC. | $16.17 | 2023 | Injectafer |
| Astellas Pharma US INC | $14.97 | 2024 | Veozah |
| Radius Health, INC. | $14.66 | 2024 | Tymlos |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.44 | 2025 | Zepbound |
| Viatris Specialty LLC | $13.72 | 2025 | Yupelri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.45 | 2023 | Trulance, Xifaxan |
| Currax Pharmaceuticals LLC | $12.36 | 2021 | |
| Insmed, INC. | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Viki Lambertus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.